Sellas End Period Cash Flow vs Free Cash Flow Analysis

SLS Stock

USD 1.17 0.03 2.50%

Sellas Life financial indicator trend analysis is much more than just breaking down Sellas Life Sciences prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Sellas Life Sciences is a good investment. Please check the relationship between Sellas Life End Period Cash Flow and its Free Cash Flow accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sellas Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

End Period Cash Flow vs Free Cash Flow

End Period Cash Flow vs Free Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Sellas Life Sciences End Period Cash Flow account and Free Cash Flow. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Sellas Life's End Period Cash Flow and Free Cash Flow is -0.34. Overlapping area represents the amount of variation of End Period Cash Flow that can explain the historical movement of Free Cash Flow in the same time period over historical financial statements of Sellas Life Sciences, assuming nothing else is changed. The correlation between historical values of Sellas Life's End Period Cash Flow and Free Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which End Period Cash Flow of Sellas Life Sciences are associated (or correlated) with its Free Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow has no effect on the direction of End Period Cash Flow i.e., Sellas Life's End Period Cash Flow and Free Cash Flow go up and down completely randomly.

Correlation Coefficient

-0.34

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

End Period Cash Flow

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Most indicators from Sellas Life's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Sellas Life Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sellas Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

At this time, Sellas Life's Tax Provision is comparatively stable compared to the past year. Sales General And Administrative To Revenue is likely to gain to 11.89 in 2024, whereas Discontinued Operations is likely to drop (11.8 M) in 2024.

Sellas Life fundamental ratios Correlations

	Total Assets	Total Stockholder Equity	Net Debt	Cash	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Stockholder Equity	Total Current Assets	Other Current Liab	Total Current Liabilities	Property Plant And Equipment Net	Retained Earnings	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Common Stock Total Equity	Short Term Investments	Other Current Assets	Total Liab	Property Plant And Equipment Gross	Common Stock	Short Long Term Debt Total	Current Deferred Revenue	Non Current Liabilities Total	Short Term Debt	Net Tangible Assets
Total Assets		0.66	-0.6	0.82	0.81	-0.53	0.63	0.92	0.61	0.81	-0.1	-0.5	-0.17	0.88	-0.1	0.85	-0.34	0.44	0.86	-0.1	0.81	0.59	0.65	0.88	0.45	0.05
Total Stockholder Equity	0.66		-0.49	0.59	0.6	-0.47	0.43	0.6	-0.06	0.11	-0.12	-0.23	-0.26	0.58	-0.05	0.55	-0.16	0.03	0.19	-0.12	0.49	0.34	0.26	0.48	0.32	0.71
Net Debt	-0.6	-0.49		-0.93	-0.94	0.17	-0.26	-0.76	-0.58	-0.41	-0.28	0.15	0.28	-0.28	0.07	-0.31	0.17	-0.08	-0.45	-0.28	-0.28	0.15	-0.29	-0.54	0.3	-0.28
Cash	0.82	0.59	-0.93		1.0	-0.3	0.44	0.92	0.68	0.62	0.2	-0.32	-0.23	0.52	-0.13	0.52	-0.27	0.17	0.66	0.2	0.49	0.21	0.38	0.7	0.03	0.18
Cash And Short Term Investments	0.81	0.6	-0.94	1.0		-0.3	0.43	0.92	0.68	0.61	0.18	-0.31	-0.22	0.51	-0.14	0.52	-0.26	0.16	0.65	0.18	0.49	0.2	0.37	0.7	0.02	0.2
Common Stock Shares Outstanding	-0.53	-0.47	0.17	-0.3	-0.3		0.1	-0.4	-0.14	-0.25	0.64	-0.28	0.11	-0.59	-0.17	-0.53	-0.25	-0.25	-0.33	0.64	-0.39	-0.35	-0.3	-0.64	-0.32	0.06
Other Stockholder Equity	0.63	0.43	-0.26	0.44	0.43	0.1		0.62	0.34	0.59	0.2	-0.97	-0.3	0.51	-0.28	0.72	-0.57	0.31	0.55	0.2	0.78	0.56	0.58	0.31	0.54	0.23
Total Current Assets	0.92	0.6	-0.76	0.92	0.92	-0.4	0.62		0.66	0.78	0.02	-0.5	-0.21	0.64	-0.18	0.73	-0.33	0.45	0.79	0.02	0.7	0.46	0.6	0.71	0.35	0.08
Other Current Liab	0.61	-0.06	-0.58	0.68	0.68	-0.14	0.34	0.66		0.83	0.16	-0.36	-0.21	0.43	-0.07	0.47	-0.18	0.18	0.83	0.16	0.48	0.26	0.33	0.64	0.03	-0.43
Total Current Liabilities	0.81	0.11	-0.41	0.62	0.61	-0.25	0.59	0.78	0.83		0.01	-0.59	-0.06	0.67	-0.17	0.71	-0.35	0.59	0.98	0.01	0.72	0.55	0.69	0.71	0.4	-0.43
Property Plant And Equipment Net	-0.1	-0.12	-0.28	0.2	0.18	0.64	0.2	0.02	0.16	0.01		-0.23	-0.03	-0.23	-0.07	-0.36	-0.25	-0.18	-0.05	1.0	-0.31	-0.23	-0.06	-0.23	-0.33	0.07
Retained Earnings	-0.5	-0.23	0.15	-0.32	-0.31	-0.28	-0.97	-0.5	-0.36	-0.59	-0.23		0.29	-0.39	0.31	-0.63	0.56	-0.3	-0.54	-0.23	-0.73	-0.51	-0.54	-0.19	-0.49	-0.12
Accounts Payable	-0.17	-0.26	0.28	-0.23	-0.22	0.11	-0.3	-0.21	-0.21	-0.06	-0.03	0.29		-0.08	-0.08	-0.41	-0.36	0.19	-0.07	-0.03	-0.42	0.03	-0.18	-0.06	0.06	-0.42
Non Current Assets Total	0.88	0.58	-0.28	0.52	0.51	-0.59	0.51	0.64	0.43	0.67	-0.23	-0.39	-0.08		0.03	0.81	-0.28	0.33	0.76	-0.23	0.77	0.62	0.58	0.89	0.48	0.01
Non Currrent Assets Other	-0.1	-0.05	0.07	-0.13	-0.14	-0.17	-0.28	-0.18	-0.07	-0.17	-0.07	0.31	-0.08	0.03		-0.06	0.14	-0.12	-0.11	-0.07	-0.09	-0.17	-0.21	0.11	-0.13	-0.06
Common Stock Total Equity	0.85	0.55	-0.31	0.52	0.52	-0.53	0.72	0.73	0.47	0.71	-0.36	-0.63	-0.41	0.81	-0.06		-0.2	0.41	0.74	-0.36	0.99	0.63	0.67	0.71	0.58	0.1
Short Term Investments	-0.34	-0.16	0.17	-0.27	-0.26	-0.25	-0.57	-0.33	-0.18	-0.35	-0.25	0.56	-0.36	-0.28	0.14	-0.2		-0.21	-0.35	-0.25	-0.24	-0.28	-0.3	-0.22	-0.24	0.05
Other Current Assets	0.44	0.03	-0.08	0.17	0.16	-0.25	0.31	0.45	0.18	0.59	-0.18	-0.3	0.19	0.33	-0.12	0.41	-0.21		0.54	-0.18	0.4	0.2	0.82	0.27	0.3	-0.35
Total Liab	0.86	0.19	-0.45	0.66	0.65	-0.33	0.55	0.79	0.83	0.98	-0.05	-0.54	-0.07	0.76	-0.11	0.74	-0.35	0.54		-0.05	0.75	0.53	0.67	0.81	0.37	-0.38
Property Plant And Equipment Gross	-0.1	-0.12	-0.28	0.2	0.18	0.64	0.2	0.02	0.16	0.01	1.0	-0.23	-0.03	-0.23	-0.07	-0.36	-0.25	-0.18	-0.05		-0.31	-0.23	-0.06	-0.23	-0.33	0.07
Common Stock	0.81	0.49	-0.28	0.49	0.49	-0.39	0.78	0.7	0.48	0.72	-0.31	-0.73	-0.42	0.77	-0.09	0.99	-0.24	0.4	0.75	-0.31		0.62	0.67	0.66	0.57	0.1
Short Long Term Debt Total	0.59	0.34	0.15	0.21	0.2	-0.35	0.56	0.46	0.26	0.55	-0.23	-0.51	0.03	0.62	-0.17	0.63	-0.28	0.2	0.53	-0.23	0.62		0.23	0.4	0.95	-0.17
Current Deferred Revenue	0.65	0.26	-0.29	0.38	0.37	-0.3	0.58	0.6	0.33	0.69	-0.06	-0.54	-0.18	0.58	-0.21	0.67	-0.3	0.82	0.67	-0.06	0.67	0.23		0.5	0.23	-0.11
Non Current Liabilities Total	0.88	0.48	-0.54	0.7	0.7	-0.64	0.31	0.71	0.64	0.71	-0.23	-0.19	-0.06	0.89	0.11	0.71	-0.22	0.27	0.81	-0.23	0.66	0.4	0.5		0.2	-0.11
Short Term Debt	0.45	0.32	0.3	0.03	0.02	-0.32	0.54	0.35	0.03	0.4	-0.33	-0.49	0.06	0.48	-0.13	0.58	-0.24	0.3	0.37	-0.33	0.57	0.95	0.23	0.2		-0.11
Net Tangible Assets	0.05	0.71	-0.28	0.18	0.2	0.06	0.23	0.08	-0.43	-0.43	0.07	-0.12	-0.42	0.01	-0.06	0.1	0.05	-0.35	-0.38	0.07	0.1	-0.17	-0.11	-0.11	-0.11

Click cells to compare fundamentals

Sellas Life Account Relationship Matchups

Sellas Life fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	16.6M	46.0M	26.3M	20.9M	6.2M	5.9M
Total Stockholder Equity	6.1M	28.0M	20.3M	4.9M	(8.0M)	(7.6M)
Net Debt	(7.1M)	(34.3M)	(20.5M)	(16.2M)	(1.6M)	(1.7M)
Cash	7.3M	35.3M	21.4M	17.1M	2.5M	2.4M
Cash And Short Term Investments	7.3M	35.3M	21.4M	17.1M	2.5M	2.4M
Common Stock Shares Outstanding	2.6M	8.0M	15.5M	19.4M	27.8M	29.2M
Liabilities And Stockholders Equity	16.6M	46.0M	26.3M	20.9M	6.2M	5.9M
Other Stockholder Equity	107.2M	145.9M	158.9M	184.8M	209.3M	145.3M
Total Current Assets	8.2M	36.9M	23.0M	17.8M	3.2M	3.0M
Other Current Liab	1.2M	1.7M	2.4M	11.4M	7.7M	6.4M
Total Current Liabilities	5.3M	12.3M	5.0M	15.5M	13.7M	19.4M
Retained Earnings	(101.1M)	(117.9M)	(138.6M)	(179.9M)	(217.2M)	(206.4M)
Accounts Payable	3.9M	4.7M	2.1M	3.4M	5.6M	3.3M
Non Current Assets Total	8.4M	9.1M	3.2M	3.2M	3.0M	2.9M
Non Currrent Assets Other	536K	614K	594K	399K	275K	261.3K
Other Current Assets	84K	1.6M	1.7M	631K	642K	609.9K
Total Liab	10.5M	18.1M	5.9M	16.1M	14.2M	25.9M
Non Current Liabilities Total	5.2M	5.8M	946K	577K	460K	437K
Net Tangible Assets	4.2M	20.3M	18.4M	2.9M	3.4M	3.2M
Retained Earnings Total Equity	(54.2M)	(81.9M)	(101.1M)	(117.9M)	(106.1M)	(111.4M)
Capital Surpluse	56.3M	87.1M	107.2M	145.9M	131.3M	135.0M
Non Current Liabilities Other	5.3M	5.0M	4.6M	296K	266.4K	253.1K
Other Assets	536K	7.2M	594K	399K	1.0	0.95
Deferred Long Term Liab	1.7M	357K	262K	239K	215.1K	204.3K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Sellas Stock Analysis

When running Sellas Life's price analysis, check to measure Sellas Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sellas Life is operating at the current time. Most of Sellas Life's value examination focuses on studying past and present price action to predict the probability of Sellas Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sellas Life's price. Additionally, you may evaluate how the addition of Sellas Life to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC